Furthermore, anti-cancer resting memory CD4+ T cells were significantly lower in Early and Mid BSD and pro-cancerous regulatory T cells were significantly higher in Mid and Late BSD compared to Survivors (Fig. S2). This evidence concerns the gene CD4 and cancer.